Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD Study of Geropharm Insulin Lispro vs Humalog in Healthy Subjects
NCT03604575Phase 1Completed
- Sponsor
- Geropharm
- Start
- Aug 2016
- Primary completion
- Dec 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of insulin lispro in diabetes mellitus (DM) (2 arms), sponsored by Geropharm. Primary endpoints: Maximum Plasma Concentration, Area Under the Concentration-Time Curve from time 0 to last measurable concentration and 2 more. Started Aug 2016; status: completed.
02
Drugs
insulin lispro
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT03604575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03604575.